PPT Slide

Evidence Standard: A Spectrum

Innovator

Generic:

Bioequivalence

New formulation

Prodrug

Alternative dosing

Coadministration with PK enhancer

Approval

Previous slide

Next slide

Back to first slide

View graphic version